Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8,746 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Optimal use of antithrombotic agents in ischemic stroke with atrial fibrillation and large artery atherosclerosis.
Kim TJ, Lee JS, Yoon JS, Oh MS, Kim JW, Park SH, Jung KH, Kim HY, Kwon JH, Choi HY, Kim HY, Eah KY, Han SW, Oh HG, Kim YJ, Shin BS, Kim CH, Kim CK, Park JM, Lee KB, Park TH, Lee J, Park MS, Choi JC, Kim C, Shin DI, Lee SJ, Kim DE, Cha JK, Kim EG, Yu KH, Hong KS, Lee YS, Lee JH, Sohn SI, Bae HJ, Lee YB, Lee JH, Rha JH, Lee BC, Chang DI, Ko SB, Yoon BW. Kim TJ, et al. Among authors: kim hy, kim yj, kim de, kim eg, kim ch, kim c, kim ck, kim jw. Int J Stroke. 2023 Aug;18(7):812-820. doi: 10.1177/17474930231158211. Epub 2023 Feb 24. Int J Stroke. 2023. PMID: 36748980
Inflammation and platelet reactivity during adjunctive colchicine versus aspirin in patients with acute coronary syndrome treated with potent P2Y12 inhibitor.
Lee SY, Cho JY, Gorog DA, Angiolillo DJ, Yun KH, Ahn JH, Koh JS, Park Y, Hwang SJ, Hwang JY, Kim JW, Jang Y, Jeong YH. Lee SY, et al. Among authors: kim jw. Front Med (Lausanne). 2024 Apr 19;11:1349577. doi: 10.3389/fmed.2024.1349577. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38841588 Free PMC article.
Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study.
Oh DY, He AR, Bouattour M, Okusaka T, Qin S, Chen LT, Kitano M, Lee CK, Kim JW, Chen MH, Suksombooncharoen T, Ikeda M, Lee MA, Chen JS, Potemski P, Burris HA 3rd, Ostwal V, Tanasanvimon S, Morizane C, Zaucha RE, McNamara MG, Avallone A, Cundom JE, Breder V, Tan B, Shimizu S, Tougeron D, Evesque L, Petrova M, Zhen DB, Gillmore R, Gupta VG, Dayyani F, Park JO, Buchschacher GL Jr, Rey F, Kim H, Wang J, Morgan C, Rokutanda N, Żotkiewicz M, Vogel A, Valle JW. Oh DY, et al. Among authors: kim jw. Lancet Gastroenterol Hepatol. 2024 May 29:S2468-1253(24)00095-5. doi: 10.1016/S2468-1253(24)00095-5. Online ahead of print. Lancet Gastroenterol Hepatol. 2024. PMID: 38823398
8,746 results